SORT1 and breast carcinoma: This finding was confirmed in an immunohistochemistry analysis in a series of 318 clinically annotated breast cancers and 53 adjacent normal tissues, showing that most normal tissues presented low levels of SORT1, while the proportion of cases with intermediate or high levels increased in cancers.